Ichor Announces Participation in Upcoming Investor Conferences

FREMONT, Calif.--(BUSINESS WIRE)-- Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced management’s participation in the following investor events taking place during the second quarter:

B. Riley Securities 26th Annual Institutional Investor Conference
The Ritz-Carlton, Marina Del Rey, CA
May 20-21, 2026

TD Cowen 54th Annual Technology, Media & Telecom Conference
InterContinental Barclay, New York, NY
May 28, 2026

The presentation material utilized during these conferences will be made accessible on the investor page of the company’s website at https://ir.ichorsystems.com.

About Ichor

We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems and components primarily for semiconductor capital equipment, as well as other industries such as defense/aerospace and medical. Our primary product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also provide precision-machined components, weldments, e-beam and laser welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products. We are headquartered in Fremont, CA.
https://ir.ichorsystems.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506312711/en/

Greg Swyt, CFO 510-897-5200
Claire McAdams, IR & Strategic Initiatives 530-265-9899
[email protected]

Source: Ichor Holdings, Ltd.

You May Also Be Interested In

• Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development
• Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters
• Arzeda Expands Leadership Team with Addition of Alex Patist and Paula Hicks